BELGIUM > Japan’s Astellas to acquire Belgium based Ogeda for around $849.08 MM

Astellas_Pharma_logo.svg Japan based Astellas is slated to acquire Belgium based Ogeda for around €800 Mn ($849.08Mn). Under the agreement, Astellas will make an initial payment of €500Mn ($530.67 Mn) in consideration of 100% of the equity in Ogeda and an additional €300Mn ($318.41Mn) with attainment of certain clinical development and regulatory milestones for fezolinetant. The closing of the transaction is subject to certain conditions More …